CVR 33377541Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)København ØFounded 15 Dec 2010
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about DUNE MEDICARE ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
8
CVR, 2020
Gross profit
-1.6M
DKK, annual report 2023
Result
-4.2M
DKK, annual report 2023
Equity
-16.8M
DKK, annual report 2023
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votessince 1 Jan 2023
CVR 33359047100% of capital and votesnotified 1 Jan 202315 Dec 2010 to 1 Jan 2023
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
May 2020, monthly: 8 employees, 4 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Apr 2020 | May 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | 8 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 |
| Series | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest May 2020, published 18 Jul 2020.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2023, DKK: Gross profit -1.6M, Operating profit -2M, Result for the year -4.2M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2023, DKK: Total assets 546.4K, Equity -16.8M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Gross profit | Not reported | Not reported | -3,918 | -1,181 | -1,645 |
| Operating profit | -3,087 | -2,223 | -3,925 | -1,188 | -1,992 |
| Result for the year | -6,020 | -5,918 | -8,714 | +26,598 | -4,186 |
| Equity | -24,560 | -30,478 | -39,193 | -12,594 | -16,780 |
| Total assets | 2,276 | 3,945 | 3,726 | 4,380 | 546 |
| Employees (average) | 1 | 1 | Not reported | 1 | 1 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | -3,083 | -2,222 | -3,920 | -1,181 | -1,985 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | Not reportednote 1 | Not reportednote 2 | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 0note 3 | 0note 3 | 36note 3 | Not reportednote 4 | 0note 3 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for DUNE MEDICARE ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 80,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 18 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 18 Nov 2026.
14 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Konkursdekret afsagt 29.08.2024 af Sø- og Handelsrettens Skifteretsafdeling
Likvidatorer:
Fratrådte:
Anders Hoffmann Kønigsfeldt, den 29.08.2024.
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Anders Hoffmann Kønigsfeldt, 2150 Nordhavn, den 19.08.2024.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 30.07.2024
Direktion:
Fratrådte:
Lian Yang, (adm. dir), den 30.07.2024.
Erhvervsstyrelsen har fået oplyst, at det ikke er muligt at komme i kontakt med selskabet på den registrerede adresse: Industriholmen 80, 1., 2650 Hvidovre.
Som følge heraf har Erhvervsstyrelsen i dag registreret selskabet med midlertidig adresse: c/o Erhvervsstyrelsen, Dahlerups Pakhus, Langelinie Allé 17, 2100 København Ø.
Erhvervsstyrelsen har ikke overtaget ledelsens opgaver eller beføjelser i selskabet.
Ny adresse: Industriholmen 80, 1., 2650 Hvidovre
Ny kommune: Hvidovre
Direktion:
Fratrådte:
Jacob Sporon-Fiedler, (adm. dir), den 14.02.2023.
Tiltrådte:
Lian Yang, (adm. dir), den 14.02.2023.
Direktion:
Fratrådte:
Elise Hellesø Rinvar, den 25.10.2021.
Tiltrådte:
Jacob Sporon-Fiedler, (adm. dir), den 25.10.2021.
CVR-nummer:
33377541.
NAVN:
DUNE MEDICARE ApS.
Adresse: Baldersbuen 29E, st. th., 2640 Hedehusene.
Kommune: Høje-Taastrup.
Direktion:
Fratrådte:
Jacob Sporon-Fiedler (adm. dir), den 10.06.2015.
Tiltrådte:
Elise Hellesø Rinvar, den 10.06.2015.
Ny adresse:
Baldersbuen 29E, st. th., Baldersbr, 2640 Hedehusene.
Ny kommune:
Høje Taastrup.
Ny adresse:
Lopholmen 32, 2690 Karlslunde.
Ny kommune:
Greve.
Ny adresse:
c/o PharmaChem Consulting ApS, Solrød Center 12B, 2680 Solrød Strand.
Ny kommune:
Solrød.
Direktion:
Udtrådt af direktionen:
Elise Hellesø Rinvar, den 16.12.2010.
Indtrådt i direktionen:
Direktør Jacob Sporon-Fiedler (adm. dir), den 16.12.2010.
Stiftelsesdato:
15.12.2010.
Seneste vedtægtsdato:
15.12.2010.
Kapital:
kr. 80.000,00.
Indbetalingsmåde:
kontant kr. 80.000,00 til kurs 465,00.
Stifter:
CVR-NR. 33359047 DUNE HOLDING ApS, Livornovej 9, 2300 København S, den 15.12.2010.
Direktion:
Elise Hellesø Rinvar (adm. dir), den 15.12.2010.
Selskabet tegnes af et medlem af direktionen.
Revision:
CVR-NR. 24252019 AP, STATSAUTORISEREDE REVISORER I/S, Nørre Farimagsgade 11, 1364 København K, den 15.12.2010.
Første regnskabsår:
15.12.2010 - 31.12.2011.
Regnskabsår:
01.01 - 31.12.
P-number 1016534257Baldersbuen 29, 2640 Hedehusene
P-number 1028513573Langelinie Allé 17, 2100 København Ø